Mamatha Serasanambati

This study establishes patient-derived melanoma organoids (PDMOs) that retain tumor-immune heterogeneity and show context-dependent responses to immune checkpoint blockade.

This paper uses single-cell Raman spectroscopy and machine learning to predict therapeutic response in melanoma, achieving >96% accuracy in cell line classification and 91% accuracy in patient drug resistance inference.